TWI746177B - 一種b肝表面抗原抑制劑的晶型及其應用 - Google Patents
一種b肝表面抗原抑制劑的晶型及其應用 Download PDFInfo
- Publication number
- TWI746177B TWI746177B TW109132274A TW109132274A TWI746177B TW I746177 B TWI746177 B TW I746177B TW 109132274 A TW109132274 A TW 109132274A TW 109132274 A TW109132274 A TW 109132274A TW I746177 B TWI746177 B TW I746177B
- Authority
- TW
- Taiwan
- Prior art keywords
- crystal form
- compound
- formula
- preparation
- hepatitis
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 58
- 102000036639 antigens Human genes 0.000 title abstract description 17
- 108091007433 antigens Proteins 0.000 title abstract description 17
- 239000000427 antigen Substances 0.000 title abstract description 11
- 239000003112 inhibitor Substances 0.000 title abstract description 7
- 208000006454 hepatitis Diseases 0.000 title description 2
- 231100000283 hepatitis Toxicity 0.000 title 1
- 208000002672 hepatitis B Diseases 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims description 53
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 229940126062 Compound A Drugs 0.000 claims description 15
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 10
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 9
- 208000000419 Chronic Hepatitis B Diseases 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 230000004580 weight loss Effects 0.000 claims description 4
- 238000001938 differential scanning calorimetry curve Methods 0.000 claims description 2
- 239000012065 filter cake Substances 0.000 claims description 2
- 238000001757 thermogravimetry curve Methods 0.000 claims description 2
- 239000005456 alcohol based solvent Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 18
- 241000700721 Hepatitis B virus Species 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000009269 systemic vascular permeability Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 101710137302 Surface antigen S Proteins 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 238000004467 single crystal X-ray diffraction Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 1
- CEVMYGZHEJSOHZ-UHFFFAOYSA-N 1-bromo-3-methoxypropane Chemical compound COCCCBr CEVMYGZHEJSOHZ-UHFFFAOYSA-N 0.000 description 1
- 206010059193 Acute hepatitis B Diseases 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- -1 Bivudine Chemical compound 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102100021202 Desmocollin-1 Human genes 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000968043 Homo sapiens Desmocollin-1 Proteins 0.000 description 1
- 101000880960 Homo sapiens Desmocollin-3 Proteins 0.000 description 1
- 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 241000283923 Marmota monax Species 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 108700027649 Mitogen-Activated Protein Kinase 3 Proteins 0.000 description 1
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 102100023132 Transcription factor Jun Human genes 0.000 description 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 1
- SAHIZENKTPRYSN-UHFFFAOYSA-N [2-[3-(phenoxymethyl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound O(C1=CC=CC=C1)CC=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 SAHIZENKTPRYSN-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
- WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 1
- 229960003205 adefovir dipivoxil Drugs 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical compound N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000004455 differential thermal analysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008406 drug-drug interaction Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003821 enantio-separation Methods 0.000 description 1
- 229960000980 entecavir Drugs 0.000 description 1
- YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000001553 hepatotropic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960001627 lamivudine Drugs 0.000 description 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229960004556 tenofovir Drugs 0.000 description 1
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
本發明公開了一種B肝表面抗原抑制劑的晶型及其製備方法,還包括所述晶型在製備B肝表面抗原抑制劑中的應用。
Description
本發明涉及一種B肝表面抗原抑制劑的晶型及其製備方法,還包括所述晶型在製備B肝表面抗原抑制劑中的應用。
本申請要求申請日為2019/9/19的中國專利申請201910887908.1的優先權。本申請引用上述中國專利申請的全文。
B型病毒性肝炎,簡稱B肝,是一種由B型肝炎病毒(Hepatitis B Virus,簡稱HBV)感染機體後所引起的疾病。B型肝炎病毒是一種嗜肝病毒,主要存在於肝細胞內並損害肝細胞,引起肝細胞炎症、壞死、纖維化。B型病毒性肝炎分急性和慢性兩種。急性B型肝炎在成年人中大多數可通過其自身的免疫機制而自愈。但是慢性B型肝炎(CHB)已成為全球健康保健所面臨的極大挑戰,同時也是引起慢性肝病,肝硬化(cirrhosis)和肝癌(HCC)的主要原因。據估計,全球有20億人感染了慢性B型肝炎病毒,超過3億5千萬人口已發展成為了B型肝炎,每年近60萬人死於慢性B型肝炎的併發症。中國是B肝高發區,B型肝炎累積病人多,危害嚴重。據資料顯示,中國現有B型肝炎病毒感染者約9300萬,而其中約2000萬患者確診為慢性B型肝炎,當中10%-20%可演變成肝硬化,1%-5%可發展成肝癌。
B肝功能性治癒的關鍵是清除HBsAg(B型肝炎病毒表面抗原),產生表面抗體。HBsAg量化是一個非常重要的生物指標。在慢性感染病人中,很少能觀察到HBsAg的減少和血清轉化,這是目前治療的終點。
B型肝炎病毒(HBV)的表面抗原蛋白在HBV侵入肝細胞的過程中起非常重要的作用,對於防治HBV的感染有重要意義。表面抗原蛋白包括大(L)、中(M)和小(S)的表面抗原蛋白,共享共同的C端S區。它們從一個開放讀碼框中表達,其不同的長度是由讀碼框三個AUG起始密碼子決定的。這三個表面抗原蛋白包括前S1 /前S2 / S,前S2 / S和S域。HBV表面抗原蛋白被整合到內質網(ER)膜,由N端信號序列啟動。它們不僅構成了病毒體的基本結構,而且還形成球狀和絲狀亞病毒顆粒(SVPs,HBsAg),聚集在ER,宿主ER和前高爾基體器,SVP包含大多S表面抗原蛋白。 L蛋白,在病毒的形態發生與核衣殼相互作用方面是至關重要的,但對於SVP的形成是沒有必要的。由於它們缺乏核衣殼,所述的SVPs 是非感染性的。SVPs大大參與了疾病進展,尤其是對B肝病毒的免疫應答,在感染者的血液裡,SVPs的量至少是病毒數量的10,000倍,誘捕了免疫系統,削弱人體對B肝病毒的免疫反應。HBsAg也可抑制人的天然免疫,能夠抑制多糖(LPS)和IL-2誘導的細胞因子產生,抑制樹狀細胞DC功能以及LPS對 ERK-1/2和c-Jun N端的干擾激酶-1/2在單核細胞的誘導活性。值得注意的是,肝硬化和肝細胞癌的疾病進展很大程度也與持續分泌的HBsAg相關。這些研究結果表明HBsAg在慢性肝炎的發展中起重要作用。
目前被批准上市的抗HBV藥物主要是免疫調節劑(干擾素-α和聚乙二醇干擾素-α-2α)和抗病毒治療藥物(拉米夫定、阿德福韋酯、恩替卡韋、替比夫定、替諾福韋、克拉夫定等)。其中,抗病毒治療藥物屬於核苷酸類藥物,其作用機制是抑制HBV DNA 的合成,並不能直接減少HBsAg水平。與延長治療一樣,核苷酸類藥物顯示HBsAg清除速度類似於自然觀察結果。
臨床已有療法降低HBsAg療效不佳,因此,開發能夠有效降低HBsAg的小分子口服抑制劑是目前臨床用藥所亟需的。
羅氏公司開發了一個名為RG7834的表面抗原抑制劑用於治療B肝,並報導了該化合物在土撥鼠抗B肝模型中的藥效:在以RG7834作為單藥使用時可以降低2.57個Log的表面抗原,降低1.7個Log的HBV-DNA。目前仍然需要有新的能夠有效降低B肝表面抗原的化合物,尤其是用作預防或治療慢性B型肝炎的藥物。
本發明的一些方案中,上述A晶型的X射線粉末衍射圖譜在下列2θ角處具有特徵衍射峰:6.30±0.20°、9.30±0.20°、9.84±0.20°、18.68±0.20°、20.16±0.20°、23.06±0.20°、24.00±0.20°和25.38±0.20°。
本發明的一些方案中,上述A晶型的X射線粉末衍射圖譜在下列2θ角處具有特徵衍射峰:6.30±0.20°、9.30±0.20°、9.84±0.20°、12.84±0.20°、18.68±0.20°、20.16±0.20°、21.26±0.20°、23.06±0.20°、24.00±0.20°、25.38±0.20°。
本發明的一些方案中,上述A晶型的X射線粉末衍射圖譜在下列2θ角處具有特徵衍射峰:6.302°、7.883°、9.301°、9.842°、12.838°、15.436°、16.580°、18.124°、18.680°、19.459°、20.161°、20.800°、21.262°、21.704°、23.057°、24.000°、24.837°、25.382°、26.244°、26.558°、27.740°、28.119°、28.827°、29.502°、29.880°、30.261°、30.762°、31.678°、32.595°、33.061°、34.347°、35.253°、35.738°、36.642°、38.619°和39.558°。
本發明的一些方案中,上述A晶型的XRPD圖譜如圖1所示。
本發明的一些方案中,上述A晶型的XRPD圖譜解析數據如表1所示:
表1:式(I)化合物A晶型的XRPD圖譜解析數據
| 編號 | 2θ角 (°) | 面間距 (Å) | 強度 | 相對強度 (%) | 編號 | 2θ角 (°) | 面間距 (Å) | 強度 | 相對強度 (%) |
| 1 | 6.302 | 14.0146 | 613 | 51.0 | 19 | 26.244 | 3.3930 | 96 | 8.0 |
| 2 | 7.883 | 11.2067 | 222 | 18.5 | 20 | 26.558 | 3.3536 | 207 | 17.2 |
| 3 | 9.301 | 9.5007 | 1202 | 100.0 | 21 | 27.740 | 3.2133 | 315 | 26.2 |
| 4 | 9.842 | 8.9801 | 541 | 45.0 | 22 | 28.119 | 3.1708 | 301 | 25.1 |
| 5 | 12.838 | 6.8901 | 434 | 36.1 | 23 | 28.827 | 3.0946 | 57 | 4.8 |
| 6 | 15.436 | 5.7357 | 272 | 22.6 | 24 | 29.502 | 3.0253 | 66 | 5.5 |
| 7 | 16.580 | 5.3424 | 253 | 21.0 | 25 | 29.880 | 2.9878 | 225 | 18.7 |
| 8 | 18.124 | 4.8907 | 64 | 5.3 | 26 | 30.261 | 2.9511 | 103 | 8.6 |
| 9 | 18.680 | 4.7463 | 650 | 54.1 | 27 | 30.762 | 2.9041 | 71 | 5.9 |
| 10 | 19.459 | 4.5580 | 167 | 13.9 | 28 | 31.678 | 2,8222 | 119 | 9.9 |
| 11 | 20.161 | 4.4009 | 978 | 81.3 | 29 | 32.595 | 2.7449 | 54 | 4.5 |
| 12 | 20.800 | 4.2671 | 327 | 27.2 | 30 | 33.061 | 2.7073 | 83 | 6.9 |
| 13 | 21.262 | 4.1755 | 397 | 33.0 | 31 | 34.347 | 2.6088 | 49 | 4.1 |
| 14 | 21.704 | 4.0914 | 115 | 9.5 | 32 | 35.235 | 2.5451 | 30 | 2.5 |
| 15 | 23.057 | 3.8542 | 854 | 71.0 | 33 | 35.738 | 2.5104 | 75 | 6.2 |
| 16 | 24.000 | 3.7049 | 686 | 57.0 | 34 | 36.642 | 2.4505 | 180 | 15.0 |
| 17 | 24.837 | 3.5819 | 158 | 13.2 | 35 | 38.619 | 2.3295 | 55 | 4.6 |
| 18 | 25.382 | 3.5062 | 656 | 54.6 | 36 | 39.558 | 2.2763 | 109 | 9.1 |
本發明的一些方案中,上述A晶型,其差示掃描量熱曲線在224.58±3℃處具有吸熱峰的峰值。
本發明的一些方案中,上述A晶型,其DSC圖譜如圖2所示。
本發明的一些方案中,上述A晶型,其熱重分析曲線在200.00±3℃時失重達0.127%;在250±3℃時又失重達0.224%。
本發明的一些方案中,上述A晶型,其TGA圖譜如圖3所示。
本發明提供了式(I)化合物A晶型的製備方法,包括將任意一種形式的式(I)化合物加入到醇類溶劑、丙酮、乙酸乙酯、乙腈或醇類溶劑、丙酮、乙腈與水中,在一定溫度下攪拌一段時間,然後過濾,將濾餅乾燥得到晶型A。
本發明的一些方案中,上述的醇類溶劑、丙酮、乙腈與水的體積比例選自1:5~3。
本發明的一些方案中,上述的醇類溶劑、丙酮、乙腈與水的體積比例選自1:1~3。
本發明的一些方案中,上述醇類溶劑選自甲醇、乙醇或異丙醇。
本發明的一些方案中,上述攪拌溫度選自25℃~65℃。
本發明的一些方案中,上述攪拌時間選自1小時~72小時。
本發明的一些方案中,上述式(I)化合物與溶劑的重量比選自1:1~30。
本發明的一些方案中,上述式(I)化合物與溶劑的重量比選自1:5~30。
本發明還提供了上述式(I)化合物,或上述式(I)化合物的A晶型在製備治療慢性B型肝炎相關藥物上的應用。
技術效果
本發明化合物有顯著的抗B肝病毒活性。本發明化合物對細胞色素P450同工酶沒有抑制,顯示藥物-藥物相互作用的風險較低;在大鼠、人和小鼠這三個種屬中的肝微粒體穩定性優秀,顯示化合物不易被代謝;具有較好的暴露量和生物利用度;在單次給藥的神經毒性研究中耐受性較好。
本發明化合物的A晶型易於獲得、物理穩定性和化學穩定性均較好,具有很高的工業應用價值和經濟價值。
定義和說明
除非另有說明,本文所用的下列術語和短語旨在含有下列含義。一個特定的短語或術語在沒有特別定義的情況下不應該被認為是不確定的或不清楚的,而應該按照普通的含義去理解。當本文出現商品名時,旨在指代其對應的商品或其活性成分。
本發明的中間體化合物可以通過本領域具有通常知識者所熟知的多種合成方法來製備,包括下面列舉的具體實施方式、其與其他化學合成方法的結合所形成的實施方式以及本領域技術上人員所熟知的等同替換方式,優選的實施方式包括但不限於本發明的實施例。
本發明具體實施方式的化學反應是在合適的溶劑中完成的,所述的溶劑須適合於本發明的化學變化及其所需的試劑和物料。為了獲得本發明的化合物,有時需要本領域具有通常知識者在已有實施方式的基礎上對合成步驟或者反應流程進行修改或選擇。
下面會通過實施例具體描述本發明,這些實施例並不意味著對本發明的任何限制。
本發明所使用的所有溶劑是市售的,無需進一步純化即可使用。
化合物經手工或者ChemDraw®軟件命名,市售化合物採用供應商目錄名稱。
本發明粉末X-射線衍射(X-ray powder diffractometer, XRPD)方法
儀器型號:丹東浩元DX-2700BH X-射線衍射儀
測試方法:大約10 ~ 20 mg樣品用於XRPD檢測。
詳細的XRPD 參數如下:
光管:Cu, kα, (λ=1.54184Ǻ).
光管電壓:40 kV,光管電流:30 mA
發散狹縫:1 mm
探測器狹縫:0.3 mm
防散射狹縫:1 mm
掃描範圍:3-40 deg
步徑:0.02 deg
步長:0.5 秒
本發明差熱分析(Differential Scanning Calorimeter, DSC)方法
儀器型號:METTLER TOLEDO DSC1 差示掃描量熱儀
測試方法:取樣品(2~ 6 mg)置於30 UL 的DSC鍍金高壓坩鍋內進行測試,以10 ℃/min的升溫速率,加熱樣品從40℃到350℃。
本發明熱重分析(Thermal Gravimetric Analyzer, TGA)方法
儀器型號:TA TGA550熱重分析儀
測試方法:取樣品(2 ~ 10 mg)置於鋁坩堝內,然後放置於鉑金吊籃內進行測試,在氮氣(N2
)條件下,以40 mL/min 的氣體流速,以10℃ /min的升溫速率,加熱樣品從40℃ 到500℃。
為讓本發明之上述和其他目的、特徵和優點能更明顯易懂,下文特舉實施例,並配合所附圖式,作詳細說明如下。
為了更好的理解本發明的內容,下面結合具體實施例來做進一步的說明,但具體的實施方式並不是對本發明的內容所做的限制。
步驟A:將1-1(10.00克,59.5毫莫耳)在0℃下溶解於二氯甲烷(500 毫升)中,然後加入磺醯氯(10.77克,79.77毫莫耳,7.98毫升),混合溶液在35℃下攪拌38小時。然後將溶液倒入300毫升飽和碳酸氫鈉水溶液中並攪拌並分液。水相經乙酸乙酯萃取(150毫升*3次),然後將合併的有機相經飽和食鹽水洗滌(40毫升*3次),並通過無水硫酸鈉乾燥,並經過減壓蒸餾得到白色殘留物。然後將白色殘留物經矽膠柱層析純化(洗脫劑:石油醚/乙酸乙酯=30/1至20/1)得到化合物1-2。1
H NMR (400MHz, MeOH-d 4
)δ 10.75 (s, 1H), 7.74 (s, 1H), 6.54 (s, 1H), 5.98 (s, 1H), 3.85 (s, 3H)。
步驟B:將1-2(8.00克,39.49毫莫耳),1-溴-3-甲氧基-丙烷(7.25克,47.39毫莫耳)溶於N,N-二甲基甲醯胺(100.00毫升),冷卻至0℃後向其中加入碳酸鉀(10.92克,78.98毫莫耳),再將混合溶液升溫至25℃並攪拌10小時。然後將乙酸乙酯(300 毫升)和水(50毫升)加入溶液中,並在25℃下攪拌10分鐘。將有機相分離出來並飽和食鹽水洗滌(40毫升*3),然後通過無水硫酸鈉乾燥,並減壓濃縮得到黃色液體。再將黃色液體經矽膠柱層析純化(洗脫劑:石油醚/乙酸乙酯=30/1至20/1)得到化合物1-3。1
H NMR (400MHz, CDCl3
) δ 10.90 (s, 1H), 7.82 (s, 1H), 6.52 (s, 1H), 4.16 (t,J
=6.0 Hz, 2H), 3.94 (s, 3H), 3.60 (t,J
=6.0 Hz, 2H), 3.38 (s, 3H), 2.13 (t,J
=6.0 Hz, 2H)。
步驟C:向1-3(3.64克,13.25毫莫耳),氯化苄(2.18克,17.23毫莫耳,1.98毫升)的N,N-二甲基甲醯胺(10.00毫升)溶液中加入碳酸鉀(4.76克,34.45毫莫耳),混合溶液在25℃下攪拌20小時。乙酸乙酯(150 毫升)和水(30毫升)加入溶液中,溶液在20℃下攪拌10分鐘。然後分離有機相並經過水(30毫升*2)和飽和食鹽水(30毫升*2)洗滌,然後通過無水硫酸鈉乾燥,並經減壓濃縮得到化合物1-4。
步驟D:將1-4(2.00克,5.48毫莫耳)和一水合氫氧化鋰(1.38克,32.89毫莫耳)加入到四氫呋喃(20毫升)和水(10毫升)的混合溶液中,之後在10~20℃下攪拌10小時。然後將溶液經乙酸乙酯/石油醚1/1(5毫升*3)洗滌。將水相調酸性至酸鹼度值1~2。再將溶液經二氯甲烷(50毫升*3)萃取,將有機相合併後經無水硫酸鈉乾燥,並減壓濃縮得到化合物2-苄氧基-5-氯-4-(3-甲氧基丙烷)苯甲酸。向2-苄氧基-5-氯-4-(3-甲氧基丙烷)苯甲酸甲酸(1.00克,2.85毫莫耳)的二氯甲烷(10.00毫升)溶液中加入氯化亞碸(508.60毫克,4.28毫莫耳,310.12微升),混合液在25℃下攪拌1小時。然後將溶液減壓濃縮得到殘留物。再將殘留物溶於甲苯,並繼續減壓濃縮得到殘留物,將殘留物1-5在氮氣環境下保存。1
H NMR (400MHz, DMSO-d 6
) δ 12.87 - 12.22 (m, 1H), 7.74 (s, 1H), 7.53 (br d,J
=7.2 Hz, 2H), 7.40 (t,J
=7.6 Hz, 2H), 7.36 - 7.30 (m, 1H), 6.94 (s, 1H), 5.27 (s, 2H), 4.20 (s, 2H), 3.50 (s, 2H), 3.26 (s, 3H), 1.98 (t,J
=6.4 Hz, 2H)。
步驟E:零下70℃下向六甲基二矽基胺基鋰(1莫耳/升,23.88毫升)的四氫呋喃(20毫升)溶液中逐滴加入(5分鐘)1-5(2.94克,7.96毫莫耳)和化合物a (1.62 g, 8.76 毫莫耳, 1.10eq
)的四氫呋喃(20毫升)溶液,然後移走冷卻槽並讓混合物持續攪拌5分鐘。再將醋酸銨(3.23克,41.95毫莫耳)和醋酸(67.85克,1.13毫莫耳)加入到混合物中,並將絕大部分四氫呋喃通過旋轉蒸發儀在60℃下除去,並將殘留物在60~65℃下加熱1.5小時。將反應混合物冷卻,然後向其中加入水(40毫升)和二氯甲烷(200毫升)。混合物攪拌10分鐘後分離,有機相經水洗(10毫升*3)和碳酸氫鈉水溶液洗,乾燥,然後濃縮得到黃色殘餘物。殘餘物再經矽膠柱層析純化(洗脫劑:石油醚/乙酸乙酯=10/1)得到化合物1-6。
步驟F:向1-6(3.00 g, 6.36 毫莫耳)的四氫呋喃(20毫升)溶液中加入活化濕鈀碳(500 毫克),溶液在25℃下於氫氣(15 psi)氣氛中攪拌2小時。然後將棕色懸濁液過濾,收集濾液,並將其減壓濃縮得到殘留物。再將殘留物經石油醚/乙酸乙酯(4/1)打漿(兩次)並過濾得到化合物1-7。
步驟G:在零下10℃下,向1-8(20.00克,178.33毫莫耳)的二氯甲烷溶液(150.00毫升)中加入吡啶(2.82克,35.67毫莫耳),然後再加入五氯化磷(37.14克,178.33毫莫耳),得到的混合物在零下10℃下反應0.5小時。反應完成後,向反應體系中加入碳酸氫鈉(44.94克,534.99毫莫耳)。反應繼續攪拌0.5小時,然後通過矽藻土過濾,並用二氯甲烷(20毫升*3)洗滌,將濾液濃縮得到殘餘物1-9。1
H NMR (400 MHz, CDCl3
)δ 7.68 (d, J=3.91 Hz, 1H), 7.35-7.44 (m, 5H), 7.22 (d, J=3.67 Hz, 1H), 6.91 (s, 1H), 5.34 (s, 2H)。
步驟H:將1-7(10.00克, 26.19 毫莫耳) ,碳酸銫(38.40克,117.86毫莫耳)和1-9(21.88克,130.95毫莫耳)的二甲亞碸(100.00毫升)溶液在100℃下攪拌16小時。反應完成後,用50毫升水淬滅反應,再用150毫升水稀釋反應液,用二氯甲烷(100毫升*3)進行萃取,再將有機相合併,用飽和食鹽水(100毫升*3)洗滌,無水硫酸鈉乾燥後,減壓濃縮得到殘餘物。殘餘物經矽膠柱層析純化(洗脫劑:二氯甲烷/乙醇=100/1至8/1)得到化合物1-10。
步驟I:將1-10經手性色譜柱製備分離(分離柱: AS(250mm*30mm,10um);流動相: [0.1% 氨水-乙醇];洗脫梯度: 40%-40%, 4.3min;120min) 純化得到兩個構型的異構體,保留時間= 2.516min 和時間=5.098 min。再將保留時間= 2.516min的異構體(55毫克,116.64微莫耳)置入甲醇(10毫升)溶液中,加入4莫耳每升的氫氧化鈉(145.80微升)。反應液在25至30℃下攪拌2小時。將反應液減壓濃縮,殘餘物溶於水(20毫升)中,用2莫耳每升的鹽酸調節pH至1~2,固體析出後過濾烘乾得到式(I)化合物(保留時間= 3.842min),ee值(對映體過量):100%。測ee值(對映體過量)方法:OD-3S_3_40_3ML 分離柱: Chiralcel OD-3 100×4.6mm I.D., 3μm 流動相: 40% 甲醇 (0.05% 二乙胺) in CO2
流速: 3mL/min 波長: 220nm。
式(I)化合物:1
H NMR (400 MHz, CDCl3
) δ 15.40 (s, 1H), 8.32 (s, 1H), 7.62 (s, 1H), 7.41 (dd, J=1.28, 4.83 Hz, 1H), 6.93-6.98 (m, 2H), 6.91 (s, 1H), 6.88 (s, 1H), 6.62 (s, 1H), 4.09 (t, J=6.24 Hz, 2H), 3.51 (t, J=5.87 Hz, 2H), 3.28 (s, 3H), 2.05 (quin, J=6.08 Hz, 2H)。
實施例2:式(I)化合物A晶型的製備
控制溫度在40℃,將式(I)化合物(1 g) 加入到反應瓶中,然後加入丙酮 (10 mL),將混合物在40℃攪拌24 小時,冷卻至室溫過濾,濾餅用丙酮 (10 mL) 洗滌,得到粗品,粗品經真空乾燥箱乾燥(45℃, 16 小時)得到式(I)化合物A晶型。
實施例3:式(I)化合物A晶型在高溫,高濕條件下的固體穩定性試驗
平行秤取2份式(I)化合物A晶型樣品,每份大約100 mg,置於玻璃樣品瓶的底部,攤成薄薄一層。樣品用鋁箔紙封瓶口,並在鋁箔紙上扎些小孔,保證樣品能與環境空氣充分接觸,置於40ºC/75%濕度條件恆溫恆濕箱。在上述條件下放置的樣品於第5天,10天取樣檢測,檢測結果與0天的初始檢測結果進行比較,試驗結果見下表2所示:
表2:A晶型在高溫,高濕條件下的固體穩定性試驗
實驗結論:本發明式(I)化合物A晶型穩定性好,易於成藥。
| 時間點(天) | 外觀 | 晶型 | 純度(%) | 總雜質(%) |
| 0 | 白色粉末 | A晶型 | 99.79 | 0.21 |
| 5 | 白色粉末 | A晶型 | 99.79 | 0.21 |
| 10 | 白色粉末 | A晶型 | 99.79 | 0.21 |
實施例4:式(I)化合物A晶型在不同溫度和濕度及光照條件下固體物理穩定性試驗
平行秤取4份式(I)化合物A晶型,每份大約100 mg,放置於玻璃樣品瓶的底部,攤成薄薄一層,鋁箔紙封瓶口,並在鋁箔紙上扎些小孔,保證樣品能與環境空氣充分接觸。把製備的4份樣品分別放置於25ºC/92.5%的相對濕度,60ºC,40ºC/75%及光照條件下,考察樣品第10天的物理穩定性。同時,單獨秤取一份大約100 mg 式(I)化合物A晶型固體,放置於玻璃樣品瓶的底部,用螺紋瓶蓋密封後,保存於-20ºC條件下,作為對照品使用。在第10天,取出所有樣品,恢復至室溫,觀察樣品外觀變化,並用XRPD檢測樣品晶型。通過對加速樣品與對照樣品的比較,判斷式(I)化合物A晶型的固體物理穩定性。下表3為A晶型固體物理穩定性實驗結果。
表3:A晶型在不同溫度和濕度條件下及光照下固體物理穩定性試驗
實驗結論:本發明式(I)化合物A晶型穩定性好,易於成藥。
| 考察 項目 | 時間點 | 0天 (-20ºC密閉保存) (對照品) | 25ºC/92.5% 相對濕度 (敞口) | 60ºC (敞口) | 40ºC/75% 相對濕度 (敞口) | 光照 |
| 晶型 | 10天 | A晶型 | A晶型 | A晶型 | A晶型 | A晶型 |
| 性狀 | 10天 | 白色粉末 | 白色粉末 | 白色粉末 | 白色粉末 | 白色粉末 |
| 純度(%) | 10天 | 99.79 | 99.80 | 99.75 | 99.79 | 99.71 |
實施例5:單晶X射線衍射檢測分析
將式(I)化合物(5 克, 11.16 毫莫耳) 加到甲醇 (15 毫升)和四氫呋喃(45 毫升)的混合液中,室溫下一次性加入三甲基矽重氮甲烷(2 莫耳/升, 8.37 毫升),然後室溫攪拌12小時。將反應液濃縮,再加入20毫升第三丁基甲醚,攪拌後過濾乾燥得到式(II)化合物。將式(II)化合物溶於甲醇,使用溶劑揮發法,室溫經過10天培養獲得式(II)化合物的單晶,衍射用晶體尺寸為0.06×0.08×0.16mm。晶體屬於三斜晶系,空間群為P1,晶胞參數為:a=13.0669(13),b=13.4585(12),c=14.4699(14)Å,α=90.348(4),β=109.374(4),γ=96.367(4) ,晶胞體積V=2383.3(4)Å3,晶胞內不對稱單位數Z=1。
用Bruker D8 venture衍射儀收集衍射強度數據,光源為CuKα輻射,掃描方式:φ/ɷ掃描,收集總衍射點數為40999個,獨立衍射點數為15341個,可觀察點數 (I/sigma≥2)為5471個。
採用直接法(Shelxs97)解析晶體結構,獲得124個非氫原子位置,使用最小二乘法修正結構參數和判別原子種類,使用幾何計算法和差值Fourier法獲得全部氫原子位置,精修後R1
=0.1357,wR2
=0.4252(w=1/α|F|2
),S=1.817。最終確定化學計量式為4(C22
H20
ClNO6
S),計算單個分子量為461.90,計算晶體密度為1.287g/cm3
。
該反應是在中性環境下進行的,條件溫和,手性碳不會發生翻轉。因此,式(I)化合物的絕對構型與式(II)化合物的一致。通過式(II)化合物的單晶數據,可以確定式(I)化合物的絕對構型。式(II)化合物單分子立體結構橢球圖見附圖4。式(II)化合物晶體的原子坐標(×104
)和等價各向同性移位參數(Å2
×103
)見表4。式(II)化合物的鍵長(Å)和鍵角[deg]見表5。式(II)化合物扭轉角度 [deg]見表6。
表4:式(II)化合物晶體的原子坐標(×104
)和等價各向同性移位參數(Å2
×103
)
表5:式(II)化合物的鍵長(Å)和鍵角[deg]
表6:式(II)化合物扭轉角度 [deg].
| x | y | z | U(eq) | |
| Cl(1) | -5132(6) | 7567(4) | 1373(5) | 110(2) |
| Cl(2) | 6227(6) | 2481(4) | 4348(5) | 117(2) |
| Cl(3) | 4871(6) | 7558(4) | 6373(5) | 111(2) |
| Cl(4) | -3762(6) | 2481(4) | -653(5) | 115(2) |
| S(1) | -5696(6) | 1040(5) | 343(5) | 114(2) |
| S(2) | 6789(6) | 8996(5) | 3561(5) | 111(2) |
| S(3) | 4294(6) | 1034(5) | 5343(5) | 116(2) |
| S(4) | -3211(6) | 8991(5) | -1439(5) | 114(2) |
| O(1) | -7185(15) | 6424(12) | 378(14) | 113(5) |
| O(1') | -1935(18) | 7130(20) | 1900(30) | 229(16) |
| O(2) | -5885(10) | 3214(9) | 844(10) | 76(4) |
| O(2') | -252(15) | 5983(19) | 1814(17) | 164(8) |
| O(3) | -862(15) | 4102(16) | 2377(15) | 132(7) |
| O(3') | 1441(14) | 3930(20) | 3151(18) | 174(10) |
| O(4) | -1920(30) | 930(20) | 2470(30) | 165(11) |
| O(4') | 3000(18) | 2905(19) | 2890(20) | 216(14) |
| O(5') | 8061(17) | 7140(20) | 6910(20) | 215(14) |
| O(5) | -489(19) | 2110(20) | 2500(20) | 190(14) |
| O(6') | 9741(14) | 5981(18) | 6858(16) | 151(7) |
| O(6) | -9850(40) | 8180(30) | -430(30) | 360(30) |
| O(7) | 8342(18) | 3625(11) | 4729(14) | 127(6) |
| O(7') | 11433(15) | 3930(20) | 8155(19) | 206(11) |
| O(8) | 7007(10) | 6823(10) | 4199(10) | 78(4) |
| O(8') | 13003(18) | 2873(18) | 7880(20) | 208(13) |
| O(9) | 1927(13) | 5900(20) | 2588(15) | 150(9) |
| O(10) | 1552(16) | 7951(19) | 2559(17) | 156(9) |
| O(11) | 2899(17) | 8900(20) | 3351(16) | 145(8) |
| O(13) | 2767(14) | 6425(10) | 5344(12) | 99(5) |
| O(14) | 4126(11) | 3191(10) | 5870(10) | 86(4) |
| O(15) | 9167(16) | 4090(17) | 7397(15) | 137(7) |
| O(16) | 9490(20) | 2100(20) | 7510(20) | 193(12) |
| O(17) | 8090(20) | 950(20) | 7440(30) | 164(12) |
| O(18) | 310(50) | 8280(30) | 4650(30) | 300(30) |
| O(19) | -1768(16) | 3632(11) | -309(14) | 118(5) |
| O(20) | -2994(11) | 6845(9) | -786(10) | 81(4) |
| O(21) | -8059(13) | 5913(18) | -2396(13) | 134(7) |
| O(22) | -8448(16) | 7930(19) | -2424(18) | 156(9) |
| O(23) | -7100(20) | 8920(30) | -1636(16) | 149(12) |
| N(1) | -4050(14) | 3042(13) | 1759(12) | 81(5) |
| N(2) | 5141(13) | 7003(14) | 3969(12) | 78(5) |
| N(3) | 5940(13) | 3050(12) | 6764(12) | 75(5) |
| N(4) | -4837(13) | 6998(13) | -1016(11) | 73(4) |
| C(1) | -4460(20) | 5715(16) | 1584(17) | 84(6) |
| C(2) | -5358(19) | 6302(15) | 1215(17) | 82(7) |
| C(3) | -6381(19) | 5788(15) | 743(16) | 87(7) |
| C(4) | -6594(18) | 4796(16) | 602(16) | 82(6) |
| C(5) | -5736(17) | 4262(14) | 972(16) | 73(6) |
| C(6) | -5241(19) | 2717(15) | 1629(16) | 83(6) |
| C(7) | -3738(17) | 4058(16) | 1742(15) | 75(6) |
| C(8) | -4671(17) | 4684(14) | 1435(15) | 76(5) |
| C(9) | -2664(19) | 4400(20) | 1937(18) | 101(8) |
| C(10) | -1850(20) | 3760(30) | 2180(20) | 113(9) |
| C(11) | -2220(20) | 2680(20) | 2174(18) | 103(8) |
| C(12) | -3263(19) | 2408(17) | 2004(15) | 84(6) |
| C(13) | -1560(40) | 1670(40) | 2330(30) | 140(20) |
| C(14) | 200(60) | 1210(50) | 2640(50) | 270(30) |
| C(15) | -5515(18) | 1598(13) | 1455(16) | 88(7) |
| C(16) | -5713(16) | 912(12) | 2196(17) | 77(6) |
| C(17) | -5980(20) | -72(17) | 1650(20) | 104(8) |
| C(18) | -5980(20) | -61(15) | 760(20) | 103(8) |
| C(19) | -8210(20) | 6070(20) | 64(17) | 109(10) |
| C(20) | -9020(20) | 6810(30) | -390(30) | 166(16) |
| C(21) | -9160(40) | 7530(40) | 90(30) | 240(30) |
| C(22) | -10350(30) | 8580(40) | -30(40) | 250(30) |
| C(23) | 5606(19) | 4307(16) | 4099(13) | 82(6) |
| C(24) | 6450(20) | 3780(16) | 4295(15) | 80(6) |
| C(25) | 7480(20) | 4178(17) | 4473(19) | 93(7) |
| C(26) | 7663(18) | 5240(16) | 4444(16) | 84(6) |
| C(27) | 6808(17) | 5803(14) | 4260(16) | 74(5) |
| C(28) | 6299(16) | 7351(14) | 4556(15) | 76(5) |
| C(29) | 4877(19) | 5987(18) | 3782(16) | 83(6) |
| C(30) | 5728(18) | 5365(17) | 4046(15) | 79(6) |
| C(31) | 3860(20) | 5640(20) | 3320(20) | 98(8) |
| C(32) | 2950(30) | 6210(20) | 3026(19) | 122(11) |
| C(33) | 3256(17) | 7260(30) | 3254(17) | 110(10) |
| C(34) | 4370(20) | 7650(17) | 3747(17) | 90(7) |
| C(35) | 2470(30) | 7970(20) | 3010(20) | 117(11) |
| C(36) | 2130(30) | 9580(30) | 3030(40) | 220(30) |
| C(37) | 6655(17) | 8416(14) | 4537(17) | 89(6) |
| C(38) | 6862(16) | 9157(14) | 5391(16) | 81(6) |
| C(39) | 7120(20) | 10130(18) | 5033(19) | 117(10) |
| C(40) | 7110(20) | 10107(19) | 4130(20) | 106(8) |
| C(41) | 9520(20) | 4000(20) | 5060(20) | 111(9) |
| C(42) | 10030(50) | 2800(40) | 5280(40) | 270(20) |
| C(45) | 5530(19) | 5731(16) | 6584(15) | 88(6) |
| C(46) | 4630(20) | 6243(13) | 6206(17) | 88(7) |
| C(47) | 3540(20) | 5804(18) | 5694(17) | 86(7) |
| C(48) | 3422(19) | 4783(16) | 5616(15) | 88(6) |
| C(49) | 4302(17) | 4218(15) | 5988(15) | 76(6) |
| C(50) | 4764(16) | 2715(14) | 6688(17) | 82(6) |
| C(51) | 6243(17) | 4071(14) | 6745(14) | 73(5) |
| C(52) | 5329(19) | 4702(17) | 6443(16) | 79(6) |
| C(53) | 7321(19) | 4390(20) | 6925(16) | 97(7) |
| C(54) | 8170(20) | 3790(20) | 7159(18) | 104(8) |
| C(55) | 7760(20) | 2690(20) | 7165(18) | 100(9) |
| C(56) | 6713(18) | 2388(18) | 6983(15) | 91(7) |
| C(57) | 8410(30) | 1730(40) | 7400(20) | 162(19) |
| C(58) | 10160(50) | 1260(40) | 7400(50) | 540(60) |
| C(59) | 4492(18) | 1626(18) | 6444(16) | 92(7) |
| C(60) | 4272(16) | 929(13) | 7181(17) | 81(6) |
| C(61) | 4040(30) | -79(19) | 6670(20) | 118(9) |
| C(62) | 4050(20) | -79(17) | 5750(20) | 118(9) |
| C(63) | 1662(19) | 5956(19) | 5048(19) | 103(7) |
| C(64) | 880(30) | 6770(20) | 4580(20) | 138(11) |
| C(65) | 980(40) | 7580(30) | 5130(30) | 220(20) |
| C(66) | -350(30) | 8550(40) | 4960(40) | 200(20) |
| C(67) | -4417(19) | 4312(15) | -921(14) | 77(6) |
| C(68) | -3580(20) | 3778(14) | -729(15) | 80(6) |
| C(69) | -2550(20) | 4235(17) | -512(16) | 92(7) |
| C(70) | -2332(17) | 5295(13) | -554(16) | 84(7) |
| C(71) | -3210(17) | 5828(16) | -762(16) | 81(6) |
| C(72) | -3670(17) | 7353(15) | -410(17) | 86(7) |
| C(73) | -5137(18) | 5977(15) | -1221(14) | 73(6) |
| C(74) | -4288(16) | 5359(14) | -950(15) | 70(5) |
| C(75) | -6193(18) | 5650(20) | -1699(15) | 96(7) |
| C(76) | -7050(20) | 6300(30) | -1968(19) | 109(11) |
| C(77) | -6700(20) | 7370(20) | -1722(17) | 93(7) |
| C(78) | -5584(19) | 7637(19) | -1240(15) | 87(6) |
| C(79) | -7510(30) | 8010(30) | -2040(30) | 139(17) |
| C(80) | -7880(20) | 9610(30) | -1960(40) | 230(30) |
| C(81) | -3339(17) | 8440(17) | -460(15) | 82(6) |
| C(82) | -3144(16) | 9142(14) | 412(15) | 79(6) |
| C(83) | -2890(30) | 10120(20) | -10(20) | 132(12) |
| C(84) | -2910(20) | 10130(20) | -890(30) | 112(9) |
| C(85) | -660(20) | 4080(20) | -90(20) | 130(10) |
| C(86) | 270(60) | 3700(50) | 640(50) | 390(30) |
| C(88) | 1700(50) | 1330(50) | 400(40) | 530(30) |
| O(24) | 140(50) | 1500(40) | 360(40) | 511(17) |
| C(87) | -310(40) | 2930(40) | -50(40) | 331(19) |
| H(1A) | -3762 | 6021 | 1916 | 101 |
| H(4A) | -7294 | 4485 | 267 | 98 |
| H(6A) | -5380 | 2915 | 2226 | 100 |
| H(9A) | -2467 | 5080 | 1907 | 121 |
| H(12A) | -3484 | 1735 | 2054 | 101 |
| H(16A) | -5680 | 1062 | 2834 | 93 |
| H(17A) | -6134 | -662 | 1934 | 125 |
| H(18A) | -6127 | -647 | 371 | 124 |
| H(19A) | -8394 | 5775 | 610 | 130 |
| H(19B) | -8316 | 5530 | -420 | 130 |
| H(20A) | -8826 | 7086 | -933 | 199 |
| H(20B) | -9732 | 6417 | -673 | 199 |
| H(21A) | -8453 | 7911 | 416 | 293 |
| H(21B) | -9437 | 7269 | 594 | 293 |
| H(22A) | -10795 | 9011 | -483 | 376 |
| H(22B) | -10809 | 8090 | 173 | 376 |
| H(22C) | -9859 | 8973 | 526 | 376 |
| H(23A) | 4912 | 3972 | 3992 | 98 |
| H(26A) | 8366 | 5552 | 4551 | 101 |
| H(28A) | 6418 | 7185 | 5239 | 91 |
| H(31A) | 3702 | 4958 | 3175 | 118 |
| H(34A) | 4562 | 8330 | 3913 | 108 |
| H(36A) | 2462 | 10242 | 3291 | 330 |
| H(36B) | 1878 | 9578 | 2326 | 330 |
| H(36C) | 1523 | 9392 | 3251 | 330 |
| H(38A) | 6829 | 9019 | 6011 | 97 |
| H(39A) | 7286 | 10720 | 5419 | 140 |
| H(40A) | 7264 | 10682 | 3823 | 127 |
| H(45A) | 6224 | 6058 | 6911 | 106 |
| H(48A) | 2729 | 4447 | 5304 | 106 |
| H(53A) | 7509 | 5071 | 6887 | 116 |
| H(56A) | 6492 | 1710 | 7001 | 109 |
| H(58A) | 10892 | 1545 | 7484 | 816 |
| H(58B) | 10167 | 779 | 7888 | 816 |
| H(58C) | 9831 | 941 | 6759 | 816 |
| H(60A) | 4277 | 1087 | 7809 | 97 |
| H(61A) | 3906 | -664 | 6967 | 141 |
| H(62A) | 3930 | -665 | 5367 | 141 |
| H(67A) | -5115 | 3980 | -1040 | 93 |
| H(70A) | -1628 | 5608 | -446 | 101 |
| H(75A) | -6386 | 4968 | -1864 | 116 |
| H(78A) | -5344 | 8310 | -1063 | 105 |
| H(80A) | -7557 | 10264 | -1658 | 348 |
| H(80B) | -8091 | 9648 | -2659 | 348 |
| H(80C) | -8507 | 9400 | -1778 | 348 |
| H(82A) | -3172 | 9010 | 1033 | 95 |
| H(83A) | -2722 | 10707 | 373 | 159 |
| H(84A) | -2763 | 10713 | -1189 | 134 |
| Cl(1)-C(2) | 1.70(2) | C(60)-C(59)-S(3) | 112.8(17) |
| Cl(2)-C(24) | 1.75(2) | C(50)-C(59)-S(3) | 126.8(18) |
| Cl(3)-C(46) | 1.765(19) | C(59)-C(60)-C(61) | 104(2) |
| Cl(4)-C(68) | 1.743(19) | C(59)-C(60)-H(60A) | 129.1 |
| S(1)-C(18) | 1.65(2) | C(16)-H(16A) | 0.93 |
| S(1)-C(15) | 1.70(2) | C(17)-C(18) | 1.29(3) |
| S(2)-C(37) | 1.67(2) | C(17)-H(17A) | 0.93 |
| S(2)-C(40) | 1.64(3) | C(18)-H(18A) | 0.93 |
| S(3)-C(62) | 1.65(2) | C(19)-C(20) | 1.52(3) |
| S(3)-C(59) | 1.70(2) | C(19)-H(19A) | 0.97 |
| S(4)-C(84) | 1.67(3) | C(19)-H(19B) | 0.97 |
| S(4)-C(81) | 1.65(2) | C(20)-C(21) | 1.26(5) |
| O(1)-C(3) | 1.40(2) | C(20)-H(20A) | 0.97 |
| O(1)-C(19) | 1.30(3) | C(20)-H(20B) | 0.97 |
| O(2)-C(5) | 1.40(2) | C(21)-H(21A) | 0.97 |
| O(2)-C(6) | 1.39(2) | C(21)-H(21B) | 0.97 |
| O(3)-C(10) | 1.25(3) | C(22)-H(22A) | 0.96 |
| O(4)-C(13) | 1.10(6) | C(22)-H(22B) | 0.96 |
| O(5)-C(13) | 1.40(6) | C(22)-H(22C) | 0.96 |
| O(5)-C(14) | 1.57(6) | C(23)-C(24) | 1.33(3) |
| O(6)-C(22) | 1.17(5) | C(23)-C(30) | 1.42(3) |
| O(6)-C(21) | 1.36(4) | C(23)-H(23A) | 0.93 |
| O(7)-C(25) | 1.37(3) | C(24)-C(25) | 1.33(3) |
| O(7)-C(41) | 1.49(3) | C(25)-C(26) | 1.43(3) |
| O(8)-C(27) | 1.38(2) | C(26)-C(27) | 1.37(3) |
| O(8)-C(28) | 1.44(2) | C(26)-H(26A) | 0.93 |
| O(9)-C(32) | 1.29(3) | C(27)-C(30) | 1.40(3) |
| O(10)-C(35) | 1.16(4) | C(28)-C(37) | 1.46(3) |
| O(11)-C(35) | 1.33(4) | C(28)-H(28A) | 0.98 |
| O(11)-C(36) | 1.40(4) | C(29)-C(31) | 1.31(3) |
| O(13)-C(47) | 1.36(3) | C(29)-C(30) | 1.42(3) |
| O(13)-C(63) | 1.43(3) | C(31)-C(32) | 1.43(4) |
| O(14)-C(49) | 1.38(2) | C(31)-H(31A) | 0.93 |
| O(14)-C(50) | 1.41(2) | C(32)-C(33) | 1.42(4) |
| O(15)-C(54) | 1.25(3) | C(33)-C(34) | 1.43(3) |
| O(16)-C(57) | 1.40(5) | C(33)-C(35) | 1.44(4) |
| O(16)-C(58) | 1.53(4) | C(34)-H(34A) | 0.93 |
| O(17)-C(57) | 1.10(6) | C(36)-H(36A) | 0.96 |
| O(18)-C(66) | 1.18(5) | C(36)-H(36B) | 0.96 |
| O(18)-C(65) | 1.37(4) | C(36)-H(36C) | 0.96 |
| O(19)-C(69) | 1.33(3) | C(37)-C(38) | 1.52(3) |
| O(19)-C(85) | 1.44(3) | C(38)-C(39) | 1.46(3) |
| O(20)-C(71) | 1.37(2) | C(38)-H(38A) | 0.93 |
| O(20)-C(72) | 1.41(2) | C(39)-C(40) | 1.30(3) |
| O(21)-C(76) | 1.31(3) | C(39)-H(39A) | 0.93 |
| O(22)-C(79) | 1.16(4) | C(40)-H(40A) | 0.93 |
| O(23)-C(79) | 1.33(5) | C(41)-C(42) | 1.81(6) |
| O(23)-C(80) | 1.42(3) | C(45)-C(46) | 1.39(3) |
| N(1)-C(12) | 1.37(2) | C(45)-C(52) | 1.38(3) |
| N(1)-C(7) | 1.38(2) | C(45)-H(45A) | 0.93 |
| N(1)-C(6) | 1.52(3) | C(46)-C(47) | 1.42(3) |
| N(2)-C(34) | 1.36(3) | C(47)-C(48) | 1.36(3) |
| N(2)-C(29) | 1.38(3) | C(48)-C(49) | 1.41(3) |
| N(2)-C(28) | 1.49(2) | C(48)-H(48A) | 0.93 |
| N(3)-C(56) | 1.38(2) | C(49)-C(52) | 1.37(3) |
| N(3)-C(51) | 1.39(2) | C(50)-C(59) | 1.48(3) |
| N(3)-C(50) | 1.52(2) | C(51)-C(53) | 1.36(3) |
| N(4)-C(78) | 1.33(3) | C(51)-C(52) | 1.49(3) |
| N(4)-C(73) | 1.39(2) | C(53)-C(54) | 1.39(4) |
| N(4)-C(72) | 1.51(3) | C(53)-H(53A) | 0.93 |
| C(1)-C(2) | 1.44(3) | C(54)-C(55) | 1.52(4) |
| C(1)-C(8) | 1.38(3) | C(55)-C(56) | 1.32(3) |
| C(1)-H(1A) | 0.93 | C(55)-C(57) | 1.60(4) |
| C(2)-C(3) | 1.38(3) | C(56)-H(56A) | 0.93 |
| C(3)-C(4) | 1.33(3) | C(58)-H(58A) | 0.96 |
| C(4)-C(5) | 1.36(3) | C(58)-H(58B) | 0.96 |
| C(4)-H(4A) | 0.93 | C(58)-H(58C) | 0.96 |
| C(5)-C(8) | 1.38(3) | C(59)-C(60) | 1.50(3) |
| C(6)-C(15) | 1.51(3) | C(60)-C(61) | 1.49(3) |
| C(6)-H(6A) | 0.98 | C(60)-H(60A) | 0.93 |
| C(7)-C(9) | 1.36(3) | C(61)-C(62) | 1.33(3) |
| C(7)-C(8) | 1.51(3) | C(61)-H(61A) | 0.93 |
| C(9)-C(10) | 1.40(4) | C(62)-H(62A) | 0.93 |
| C(9)-H(9A) | 0.93 | C(63)-C(64) | 1.58(3) |
| C(10)-C(11) | 1.48(4) | C(64)-C(65) | 1.32(5) |
| C(11)-C(12) | 1.32(3) | C(67)-C(68) | 1.32(3) |
| C(11)-C(13) | 1.67(5) | C(67)-C(74) | 1.40(3) |
| C(12)-H(12A) | 0.93 | C(67)-H(67A) | 0.93 |
| C(15)-C(16) | 1.49(3) | C(68)-C(69) | 1.35(3) |
| C(16)-C(17) | 1.48(3) | C(69)-C(70) | 1.43(3) |
| C(73)-C(75) | 1.34(3) | C(70)-C(71) | 1.37(3) |
| C(73)-C(74) | 1.41(3) | C(70)-H(70A) | 0.93 |
| C(75)-C(76) | 1.45(4) | C(71)-C(74) | 1.42(3) |
| C(75)-H(75A) | 0.93 | C(72)-C(81) | 1.49(3) |
| C(76)-C(77) | 1.46(4) | C(10)-C(9)-H(9A) | 118.7 |
| C(77)-C(78) | 1.39(3) | O(3)-C(10)-C(9) | 121(3) |
| C(77)-C(79) | 1.41(4) | O(3)-C(10)-C(11) | 123(3) |
| C(78)-H(78A) | 0.93 | C(9)-C(10)-C(11) | 116(3) |
| C(80)-H(80A) | 0.96 | C(12)-C(11)-C(10) | 118(3) |
| C(80)-H(80B) | 0.96 | C(12)-C(11)-C(13) | 109(3) |
| C(80)-H(80C) | 0.96 | C(10)-C(11)-C(13) | 133(3) |
| C(81)-C(82) | 1.51(3) | C(11)-C(12)-N(1) | 125(2) |
| C(82)-C(83) | 1.50(4) | C(11)-C(12)-H(12A) | 117.3 |
| C(82)-H(82A) | 0.93 | N(1)-C(12)-H(12A) | 118 |
| C(83)-C(84) | 1.26(4) | O(4)-C(13)-O(5) | 134(4) |
| C(83)-H(83A) | 0.93 | O(4)-C(13)-C(11) | 124(4) |
| C(84)-H(84A) | 0.93 | O(5)-C(13)-C(11) | 100(4) |
| C(85)-C(86) | 1.47(7) | C(6)-C(15)-C(16) | 123.8(18) |
| C(86)-C(87) | 1.39(7) | C(6)-C(15)-S(1) | 121.0(16) |
| C(88)-O(24) | 2.06(5) | C(16)-C(15)-S(1) | 115.1(14) |
| O(24)-C(87) | 2.10(7) | C(17)-C(16)-C(15) | 101.8(19) |
| C(18)-S(1)-C(15) | 90.0(12) | C(17)-C(16)-H(16A) | 129.6 |
| C(37)-S(2)-C(40) | 93.6(13) | C(15)-C(16)-H(16A) | 128.5 |
| C(62)-S(3)-C(59) | 92.8(13) | C(18)-C(17)-C(16) | 116(2) |
| C(84)-S(4)-C(81) | 93.4(14) | C(18)-C(17)-H(17A) | 122 |
| C(3)-O(1)-C(19) | 120.4(19) | C(16)-C(17)-H(17A) | 121.9 |
| C(5)-O(2)-C(6) | 114.7(15) | C(17)-C(18)-S(1) | 117.0(19) |
| C(13)-O(5)-C(14) | 104(4) | C(17)-C(18)-H(18A) | 121.9 |
| C(22)-O(6)-C(21) | 119(5) | S(1)-C(18)-H(18A) | 121.1 |
| C(25)-O(7)-C(41) | 127.4(19) | O(1)-C(19)-C(20) | 116(3) |
| C(27)-O(8)-C(28) | 111.7(15) | O(1)-C(19)-H(19A) | 108.5 |
| C(35)-O(11)-C(36) | 112(3) | C(20)-C(19)-H(19A) | 108 |
| C(47)-O(13)-C(63) | 115.4(18) | O(1)-C(19)-H(19B) | 108 |
| C(49)-O(14)-C(50) | 112.9(14) | C(20)-C(19)-H(19B) | 108.1 |
| C(57)-O(16)-C(58) | 112(4) | H(19A)-C(19)-H(19B) | 107.5 |
| C(66)-O(18)-C(65) | 121(4) | C(21)-C(20)-C(19) | 123(4) |
| C(69)-O(19)-C(85) | 118(2) | C(21)-C(20)-H(20A) | 108.8 |
| C(71)-O(20)-C(72) | 111.7(16) | C(19)-C(20)-H(20A) | 106 |
| C(79)-O(23)-C(80) | 111(3) | C(21)-C(20)-H(20B) | 104.3 |
| C(12)-N(1)-C(7) | 119.0(19) | C(19)-C(20)-H(20B) | 107.1 |
| C(12)-N(1)-C(6) | 123.5(19) | H(20A)-C(20)-H(20B) | 106.5 |
| C(7)-N(1)-C(6) | 117.1(16) | C(20)-C(21)-O(6) | 117(5) |
| C(34)-N(2)-C(29) | 122(2) | C(20)-C(21)-H(21A) | 106 |
| C(34)-N(2)-C(28) | 121(2) | O(6)-C(21)-H(21A) | 105.9 |
| C(29)-N(2)-C(28) | 116.2(17) | C(20)-C(21)-H(21B) | 110.6 |
| C(56)-N(3)-C(51) | 120.9(18) | O(6)-C(21)-H(21B) | 109.7 |
| C(56)-N(3)-C(50) | 121.2(18) | H(21A)-C(21)-H(21B) | 107.3 |
| C(51)-N(3)-C(50) | 117.3(15) | O(6)-C(22)-H(22A) | 110.4 |
| C(78)-N(4)-C(73) | 121.1(19) | O(6)-C(22)-H(22B) | 112.3 |
| C(78)-N(4)-C(72) | 120.2(18) | H(22A)-C(22)-H(22B) | 109.5 |
| C(73)-N(4)-C(72) | 118.2(16) | O(6)-C(22)-H(22C) | 105.6 |
| C(2)-C(1)-C(8) | 119(2) | H(22A)-C(22)-H(22C) | 109.5 |
| C(2)-C(1)-H(1A) | 120.4 | H(22B)-C(22)-H(22C) | 109.5 |
| C(8)-C(1)-H(1A) | 120.8 | C(24)-C(23)-C(30) | 122(2) |
| C(1)-C(2)-C(3) | 117.1(19) | C(24)-C(23)-H(23A) | 119.1 |
| C(1)-C(2)-Cl(1) | 120.0(17) | C(30)-C(23)-H(23A) | 118.6 |
| C(3)-C(2)-Cl(1) | 123(2) | C(23)-C(24)-C(25) | 124(2) |
| O(1)-C(3)-C(4) | 122(2) | C(23)-C(24)-Cl(2) | 119(2) |
| O(1)-C(3)-C(2) | 113(2) | C(25)-C(24)-Cl(2) | 116(2) |
| C(4)-C(3)-C(2) | 125(2) | C(24)-C(25)-O(7) | 123(2) |
| C(3)-C(4)-C(5) | 117(2) | C(24)-C(25)-C(26) | 117(2) |
| C(3)-C(4)-H(4A) | 121.7 | O(7)-C(25)-C(26) | 120(2) |
| C(5)-C(4)-H(4A) | 121.7 | C(27)-C(26)-C(25) | 120(2) |
| C(8)-C(5)-O(2) | 115.4(18) | C(27)-C(26)-H(26A) | 119.7 |
| C(8)-C(5)-C(4) | 124.2(19) | C(25)-C(26)-H(26A) | 120 |
| O(2)-C(5)-C(4) | 120.3(18) | O(8)-C(27)-C(26) | 118.9(19) |
| O(2)-C(6)-C(15) | 110.8(17) | O(8)-C(27)-C(30) | 118.8(19) |
| O(2)-C(6)-N(1) | 108.3(16) | C(26)-C(27)-C(30) | 122(2) |
| C(15)-C(6)-N(1) | 111.3(17) | O(8)-C(28)-C(37) | 106.3(17) |
| O(2)-C(6)-H(6A) | 108.9 | O(8)-C(28)-N(2) | 109.1(15) |
| C(15)-C(6)-H(6A) | 108.5 | C(37)-C(28)-N(2) | 116.3(17) |
| N(1)-C(6)-H(6A) | 108.9 | O(8)-C(28)-H(28A) | 108.1 |
| C(9)-C(7)-N(1) | 120(2) | C(37)-C(28)-H(28A) | 108.3 |
| C(9)-C(7)-C(8) | 126(2) | N(2)-C(28)-H(28A) | 108.5 |
| N(1)-C(7)-C(8) | 114.6(18) | C(31)-C(29)-N(2) | 118(2) |
| C(5)-C(8)-C(1) | 118(2) | C(31)-C(29)-C(30) | 123(2) |
| C(5)-C(8)-C(7) | 121.7(18) | N(2)-C(29)-C(30) | 119(2) |
| C(1)-C(8)-C(7) | 119.9(19) | C(29)-C(30)-C(27) | 119(2) |
| C(7)-C(9)-C(10) | 122(3) | C(29)-C(30)-C(23) | 127(2) |
| C(7)-C(9)-H(9A) | 118.8 | C(27)-C(30)-C(23) | 115(2) |
| O(9)-C(32)-C(33) | 119(3) | C(29)-C(31)-C(32) | 127(3) |
| C(31)-C(32)-C(33) | 113(3) | C(29)-C(31)-H(31A) | 116.7 |
| C(34)-C(33)-C(35) | 116(3) | C(32)-C(31)-H(31A) | 116.7 |
| C(34)-C(33)-C(32) | 121(2) | O(9)-C(32)-C(31) | 128(3) |
| C(35)-C(33)-C(32) | 122(3) | C(61)-C(60)-H(60A) | 127.2 |
| N(2)-C(34)-C(33) | 118(2) | C(62)-C(61)-C(60) | 115(3) |
| N(2)-C(34)-H(34A) | 120.9 | C(62)-C(61)-H(61A) | 122.3 |
| C(33)-C(34)-H(34A) | 120.8 | C(60)-C(61)-H(61A) | 122.6 |
| O(10)-C(35)-O(11) | 110(3) | C(61)-C(62)-S(3) | 115(2) |
| O(10)-C(35)-C(33) | 136(3) | C(61)-C(62)-H(62A) | 122.1 |
| O(11)-C(35)-C(33) | 114(3) | S(3)-C(62)-H(62A) | 122.6 |
| O(11)-C(36)-H(36A) | 110 | O(13)-C(63)-C(64) | 108(2) |
| O(11)-C(36)-H(36B) | 109.1 | C(65)-C(64)-C(63) | 117(3) |
| H(36A)-C(36)-H(36B) | 109.5 | C(64)-C(65)-O(18) | 113(5) |
| O(11)-C(36)-H(36C) | 109.2 | C(68)-C(67)-C(74) | 123(2) |
| H(36A)-C(36)-H(36C) | 109.5 | C(68)-C(67)-H(67A) | 118.5 |
| H(36B)-C(36)-H(36C) | 109.5 | C(74)-C(67)-H(67A) | 118.9 |
| C(38)-C(37)-C(28) | 124(2) | C(67)-C(68)-C(69) | 121(2) |
| C(38)-C(37)-S(2) | 111.0(14) | C(67)-C(68)-Cl(4) | 121.6(19) |
| C(28)-C(37)-S(2) | 125.2(18) | C(69)-C(68)-Cl(4) | 117.7(19) |
| C(39)-C(38)-C(37) | 105.2(19) | O(19)-C(69)-C(68) | 116(2) |
| C(39)-C(38)-H(38A) | 127.4 | O(19)-C(69)-C(70) | 123(2) |
| C(37)-C(38)-H(38A) | 127.4 | C(68)-C(69)-C(70) | 121(2) |
| C(40)-C(39)-C(38) | 115(2) | C(71)-C(70)-C(69) | 117(2) |
| C(40)-C(39)-H(39A) | 122.9 | C(71)-C(70)-H(70A) | 122.2 |
| C(38)-C(39)-H(39A) | 122.5 | C(69)-C(70)-H(70A) | 121.1 |
| C(39)-C(40)-S(2) | 116(2) | O(20)-C(71)-C(70) | 116.5(19) |
| C(39)-C(40)-H(40A) | 122 | O(20)-C(71)-C(74) | 121.4(18) |
| S(2)-C(40)-H(40A) | 122.4 | C(70)-C(71)-C(74) | 122(2) |
| O(7)-C(41)-C(42) | 97(2) | O(20)-C(72)-N(4) | 107.3(16) |
| C(46)-C(45)-C(52) | 115(2) | O(20)-C(72)-C(81) | 106.2(18) |
| C(46)-C(45)-H(45A) | 122.3 | N(4)-C(72)-C(81) | 114.5(16) |
| C(52)-C(45)-H(45A) | 122.2 | C(75)-C(73)-N(4) | 119(2) |
| C(45)-C(46)-C(47) | 125.9(19) | C(75)-C(73)-C(74) | 125(2) |
| C(45)-C(46)-Cl(3) | 116.0(19) | N(4)-C(73)-C(74) | 116.9(18) |
| C(47)-C(46)-Cl(3) | 118.1(17) | C(71)-C(74)-C(67) | 117(2) |
| O(13)-C(47)-C(48) | 128(2) | C(71)-C(74)-C(73) | 117.1(18) |
| O(13)-C(47)-C(46) | 118(2) | C(67)-C(74)-C(73) | 126.1(19) |
| C(48)-C(47)-C(46) | 114(2) | C(73)-C(75)-C(76) | 123(3) |
| C(47)-C(48)-C(49) | 123(2) | C(73)-C(75)-H(75A) | 118.7 |
| C(47)-C(48)-H(48A) | 117.9 | C(76)-C(75)-H(75A) | 118.1 |
| C(49)-C(48)-H(48A) | 119.4 | O(21)-C(76)-C(75) | 119(3) |
| O(14)-C(49)-C(52) | 120.8(19) | O(21)-C(76)-C(77) | 124(3) |
| O(14)-C(49)-C(48) | 119.8(19) | C(75)-C(76)-C(77) | 116(2) |
| C(52)-C(49)-C(48) | 119(2) | C(78)-C(77)-C(79) | 127(3) |
| O(14)-C(50)-C(59) | 106.3(16) | C(78)-C(77)-C(76) | 116(3) |
| O(14)-C(50)-N(3) | 105.0(16) | C(79)-C(77)-C(76) | 117(3) |
| C(59)-C(50)-N(3) | 110.4(17) | N(4)-C(78)-C(77) | 125(2) |
| C(53)-C(51)-N(3) | 118(2) | N(4)-C(78)-H(78A) | 117.6 |
| C(53)-C(51)-C(52) | 126(2) | C(77)-C(78)-H(78A) | 117.8 |
| N(3)-C(51)-C(52) | 115.8(18) | O(22)-C(79)-O(23) | 113(4) |
| C(49)-C(52)-C(45) | 122(2) | O(22)-C(79)-C(77) | 137(5) |
| C(49)-C(52)-C(51) | 117(2) | O(23)-C(79)-C(77) | 109(4) |
| C(45)-C(52)-C(51) | 121(2) | O(23)-C(80)-H(80A) | 109.5 |
| C(51)-C(53)-C(54) | 126(3) | O(23)-C(80)-H(80B) | 108.7 |
| C(51)-C(53)-H(53A) | 116.9 | H(80A)-C(80)-H(80B) | 109.5 |
| C(54)-C(53)-H(53A) | 116.7 | O(23)-C(80)-H(80C) | 110.2 |
| O(15)-C(54)-C(53) | 126(3) | H(80A)-C(80)-H(80C) | 109.5 |
| O(15)-C(54)-C(55) | 122(3) | H(80B)-C(80)-H(80C) | 109.5 |
| C(53)-C(54)-C(55) | 112(2) | C(82)-C(81)-C(72) | 120(2) |
| C(56)-C(55)-C(54) | 122(2) | C(82)-C(81)-S(4) | 114.5(17) |
| C(56)-C(55)-C(57) | 108(3) | C(72)-C(81)-S(4) | 125.2(16) |
| C(54)-C(55)-C(57) | 131(3) | C(83)-C(82)-C(81) | 100(2) |
| C(55)-C(56)-N(3) | 122(2) | C(83)-C(82)-H(82A) | 129.9 |
| C(55)-C(56)-H(56A) | 118.5 | C(81)-C(82)-H(82A) | 130.3 |
| N(3)-C(56)-H(56A) | 120 | C(84)-C(83)-C(82) | 120(3) |
| O(17)-C(57)-O(16) | 126(3) | C(84)-C(83)-H(83A) | 120.1 |
| O(17)-C(57)-C(55) | 129(4) | C(82)-C(83)-H(83A) | 119.9 |
| O(16)-C(57)-C(55) | 105(4) | C(83)-C(84)-S(4) | 112(3) |
| O(16)-C(58)-H(58A) | 109.3 | C(83)-C(84)-H(84A) | 124 |
| O(16)-C(58)-H(58B) | 104.4 | S(4)-C(84)-H(84A) | 123.7 |
| H(58A)-C(58)-H(58B) | 109.5 | O(19)-C(85)-C(86) | 123(4) |
| O(16)-C(58)-H(58C) | 114.6 | C(87)-C(86)-C(85) | 71(4) |
| H(58A)-C(58)-H(58C) | 109.5 | C(88)-O(24)-C(87) | 113(3) |
| H(58B)-C(58)-H(58C) | 109.5 | C(86)-C(87)-O(24) | 114(5) |
| C(60)-C(59)-C(50) | 120(2) |
| C(8)-C(1)-C(2)-C(3) | 1(3) | C(52)-C(45)-C(46)-Cl(3) | -179.6(16) |
| C(8)-C(1)-C(2)-Cl(1) | -179.3(17) | C(63)-O(13)-C(47)-C(48) | 15(3) |
| C(19)-O(1)-C(3)-C(4) | 14(4) | C(63)-O(13)-C(47)-C(46) | -166(2) |
| C(19)-O(1)-C(3)-C(2) | -168(2) | C(45)-C(46)-C(47)-O(13) | -178(2) |
| C(1)-C(2)-C(3)-O(1) | -177.7(19) | Cl(3)-C(46)-C(47)-O(13) | 1(3) |
| Cl(1)-C(2)-C(3)-O(1) | 3(3) | C(45)-C(46)-C(47)-C(48) | 2(3) |
| C(1)-C(2)-C(3)-C(4) | 0(4) | Cl(3)-C(46)-C(47)-C(48) | -178.7(16) |
| Cl(1)-C(2)-C(3)-C(4) | 179.9(19) | O(13)-C(47)-C(48)-C(49) | 178(2) |
| O(1)-C(3)-C(4)-C(5) | 178(2) | C(46)-C(47)-C(48)-C(49) | -2(3) |
| C(2)-C(3)-C(4)-C(5) | 1(4) | C(50)-O(14)-C(49)-C(52) | 39(3) |
| C(6)-O(2)-C(5)-C(8) | 39(3) | C(50)-O(14)-C(49)-C(48) | -143(2) |
| C(6)-O(2)-C(5)-C(4) | -145(2) | C(47)-C(48)-C(49)-O(14) | -179(2) |
| C(3)-C(4)-C(5)-C(8) | -3(4) | C(47)-C(48)-C(49)-C(52) | 0(3) |
| C(3)-C(4)-C(5)-O(2) | -179(2) | C(49)-O(14)-C(50)-C(59) | -179.4(18) |
| C(5)-O(2)-C(6)-C(15) | 176.0(17) | C(49)-O(14)-C(50)-N(3) | -62(2) |
| C(5)-O(2)-C(6)-N(1) | -61.6(19) | C(56)-N(3)-C(50)-O(14) | -138.7(18) |
| C(12)-N(1)-C(6)-O(2) | -141.7(18) | C(51)-N(3)-C(50)-O(14) | 50(2) |
| C(7)-N(1)-C(6)-O(2) | 46(2) | C(56)-N(3)-C(50)-C(59) | -25(3) |
| C(12)-N(1)-C(6)-C(15) | -20(3) | C(51)-N(3)-C(50)-C(59) | 164.4(17) |
| C(7)-N(1)-C(6)-C(15) | 168.3(17) | C(56)-N(3)-C(51)-C(53) | 2(3) |
| C(12)-N(1)-C(7)-C(9) | 2(3) | C(50)-N(3)-C(51)-C(53) | 172.7(19) |
| C(6)-N(1)-C(7)-C(9) | 174(2) | C(56)-N(3)-C(51)-C(52) | 176.5(18) |
| C(12)-N(1)-C(7)-C(8) | 178.4(18) | C(50)-N(3)-C(51)-C(52) | -12(3) |
| C(6)-N(1)-C(7)-C(8) | -9(3) | O(14)-C(49)-C(52)-C(45) | -179(2) |
| O(2)-C(5)-C(8)-C(1) | 180.0(19) | C(48)-C(49)-C(52)-C(45) | 2(3) |
| C(4)-C(5)-C(8)-C(1) | 4(4) | O(14)-C(49)-C(52)-C(51) | 4(3) |
| O(2)-C(5)-C(8)-C(7) | 2(3) | C(48)-C(49)-C(52)-C(51) | -174.9(19) |
| C(4)-C(5)-C(8)-C(7) | -174(2) | C(46)-C(45)-C(52)-C(49) | -2(3) |
| C(2)-C(1)-C(8)-C(5) | -3(3) | C(46)-C(45)-C(52)-C(51) | 175.2(19) |
| C(2)-C(1)-C(8)-C(7) | 175.1(19) | C(53)-C(51)-C(52)-C(49) | 159(2) |
| C(9)-C(7)-C(8)-C(5) | 160(2) | N(3)-C(51)-C(52)-C(49) | -16(3) |
| N(1)-C(7)-C(8)-C(5) | -16(3) | C(53)-C(51)-C(52)-C(45) | -19(3) |
| C(9)-C(7)-C(8)-C(1) | -18(3) | N(3)-C(51)-C(52)-C(45) | 166.9(19) |
| N(1)-C(7)-C(8)-C(1) | 166(2) | N(3)-C(51)-C(53)-C(54) | -2(3) |
| N(1)-C(7)-C(9)-C(10) | -2(4) | C(52)-C(51)-C(53)-C(54) | -177(2) |
| C(8)-C(7)-C(9)-C(10) | -177(2) | C(51)-C(53)-C(54)-O(15) | -174(2) |
| C(7)-C(9)-C(10)-O(3) | -179(2) | C(51)-C(53)-C(54)-C(55) | 2(4) |
| C(7)-C(9)-C(10)-C(11) | 3(4) | O(15)-C(54)-C(55)-C(56) | 175(2) |
| O(3)-C(10)-C(11)-C(12) | 177(2) | C(53)-C(54)-C(55)-C(56) | -1(4) |
| C(9)-C(10)-C(11)-C(12) | -4(4) | O(15)-C(54)-C(55)-C(57) | -3(5) |
| O(3)-C(10)-C(11)-C(13) | -4(5) | C(53)-C(54)-C(55)-C(57) | -179(2) |
| C(9)-C(10)-C(11)-C(13) | 175(3) | C(54)-C(55)-C(56)-N(3) | 1(4) |
| C(10)-C(11)-C(12)-N(1) | 5(4) | C(57)-C(55)-C(56)-N(3) | 179(2) |
| C(13)-C(11)-C(12)-N(1) | -174(2) | C(51)-N(3)-C(56)-C(55) | -1(3) |
| C(7)-N(1)-C(12)-C(11) | -4(3) | C(50)-N(3)-C(56)-C(55) | -172(2) |
| C(6)-N(1)-C(12)-C(11) | -176(2) | C(58)-O(16)-C(57)-O(17) | 18(6) |
| C(14)-O(5)-C(13)-O(4) | 18(8) | C(58)-O(16)-C(57)-C(55) | -161(3) |
| C(14)-O(5)-C(13)-C(11) | -179(3) | C(56)-C(55)-C(57)-O(17) | -3(6) |
| C(12)-C(11)-C(13)-O(4) | -14(6) | C(54)-C(55)-C(57)-O(17) | 176(4) |
| C(10)-C(11)-C(13)-O(4) | 166(5) | C(56)-C(55)-C(57)-O(16) | 176(2) |
| C(12)-C(11)-C(13)-O(5) | -180(2) | C(54)-C(55)-C(57)-O(16) | -6(4) |
| C(10)-C(11)-C(13)-O(5) | 1(4) | O(14)-C(50)-C(59)-C(60) | -134.1(19) |
| O(2)-C(6)-C(15)-C(16) | -132(2) | N(3)-C(50)-C(59)-C(60) | 113(2) |
| N(1)-C(6)-C(15)-C(16) | 107(2) | O(14)-C(50)-C(59)-S(3) | 41(3) |
| O(2)-C(6)-C(15)-S(1) | 44(2) | N(3)-C(50)-C(59)-S(3) | -73(2) |
| N(1)-C(6)-C(15)-S(1) | -77(2) | C(62)-S(3)-C(59)-C(60) | -4.8(18) |
| C(18)-S(1)-C(15)-C(6) | -178(2) | C(62)-S(3)-C(59)-C(50) | 180(2) |
| C(18)-S(1)-C(15)-C(16) | -2.0(19) | C(50)-C(59)-C(60)-C(61) | -180(2) |
| C(6)-C(15)-C(16)-C(17) | 178(2) | S(3)-C(59)-C(60)-C(61) | 5(2) |
| S(1)-C(15)-C(16)-C(17) | 2(2) | C(59)-C(60)-C(61)-C(62) | -3(3) |
| C(15)-C(16)-C(17)-C(18) | -1(3) | C(60)-C(61)-C(62)-S(3) | -1(4) |
| C(16)-C(17)-C(18)-S(1) | -1(4) | C(59)-S(3)-C(62)-C(61) | 3(3) |
| C(15)-S(1)-C(18)-C(17) | 1(3) | C(47)-O(13)-C(63)-C(64) | -175(2) |
| C(3)-O(1)-C(19)-C(20) | -176(2) | O(13)-C(63)-C(64)-C(65) | -56(4) |
| O(1)-C(19)-C(20)-C(21) | -65(5) | C(63)-C(64)-C(65)-O(18) | 177(4) |
| C(19)-C(20)-C(21)-O(6) | 175(4) | C(66)-O(18)-C(65)-C(64) | 121(7) |
| C(22)-O(6)-C(21)-C(20) | 149(6) | C(74)-C(67)-C(68)-C(69) | 3(4) |
| C(30)-C(23)-C(24)-C(25) | 1(4) | C(74)-C(67)-C(68)-Cl(4) | 177.6(16) |
| C(30)-C(23)-C(24)-Cl(2) | 179.9(15) | C(85)-O(19)-C(69)-C(68) | 179(2) |
| C(23)-C(24)-C(25)-O(7) | 176(2) | C(85)-O(19)-C(69)-C(70) | 2(4) |
| Cl(2)-C(24)-C(25)-O(7) | -3(3) | C(67)-C(68)-C(69)-O(19) | 179(2) |
| C(23)-C(24)-C(25)-C(26) | 0(4) | Cl(4)-C(68)-C(69)-O(19) | 3(3) |
| Cl(2)-C(24)-C(25)-C(26) | -179.1(16) | C(67)-C(68)-C(69)-C(70) | -5(4) |
| C(41)-O(7)-C(25)-C(24) | -172(2) | Cl(4)-C(68)-C(69)-C(70) | -179.9(17) |
| C(41)-O(7)-C(25)-C(26) | 4(4) | O(19)-C(69)-C(70)-C(71) | -179(2) |
| C(24)-C(25)-C(26)-C(27) | 1(4) | C(68)-C(69)-C(70)-C(71) | 4(4) |
| O(7)-C(25)-C(26)-C(27) | -175(2) | C(72)-O(20)-C(71)-C(70) | -144(2) |
| C(28)-O(8)-C(27)-C(26) | -147(2) | C(72)-O(20)-C(71)-C(74) | 37(3) |
| C(28)-O(8)-C(27)-C(30) | 38(3) | C(69)-C(70)-C(71)-O(20) | 179.0(19) |
| C(25)-C(26)-C(27)-O(8) | -177.5(19) | C(69)-C(70)-C(71)-C(74) | -1(4) |
| C(25)-C(26)-C(27)-C(30) | -3(4) | C(71)-O(20)-C(72)-N(4) | -58(2) |
| C(27)-O(8)-C(28)-C(37) | 175.0(17) | C(71)-O(20)-C(72)-C(81) | 178.9(17) |
| C(27)-O(8)-C(28)-N(2) | -59(2) | C(78)-N(4)-C(72)-O(20) | -142.4(18) |
| C(34)-N(2)-C(28)-O(8) | -144.3(18) | C(73)-N(4)-C(72)-O(20) | 46(2) |
| C(29)-N(2)-C(28)-O(8) | 44(2) | C(78)-N(4)-C(72)-C(81) | -25(3) |
| C(34)-N(2)-C(28)-C(37) | -24(3) | C(73)-N(4)-C(72)-C(81) | 163.5(18) |
| C(29)-N(2)-C(28)-C(37) | 164.1(19) | C(78)-N(4)-C(73)-C(75) | 3(3) |
| C(34)-N(2)-C(29)-C(31) | 4(3) | C(72)-N(4)-C(73)-C(75) | 175.1(18) |
| C(28)-N(2)-C(29)-C(31) | 176(2) | C(78)-N(4)-C(73)-C(74) | -179.6(18) |
| C(34)-N(2)-C(29)-C(30) | -179.2(19) | C(72)-N(4)-C(73)-C(74) | -8(3) |
| C(28)-N(2)-C(29)-C(30) | -8(3) | O(20)-C(71)-C(74)-C(67) | 179.0(18) |
| C(31)-C(29)-C(30)-C(27) | 161(2) | C(70)-C(71)-C(74)-C(67) | -1(3) |
| N(2)-C(29)-C(30)-C(27) | -16(3) | O(20)-C(71)-C(74)-C(73) | 4(3) |
| C(31)-C(29)-C(30)-C(23) | -17(4) | C(70)-C(71)-C(74)-C(73) | -176(2) |
| N(2)-C(29)-C(30)-C(23) | 166.2(19) | C(68)-C(67)-C(74)-C(71) | 0(3) |
| O(8)-C(27)-C(30)-C(29) | 0(3) | C(68)-C(67)-C(74)-C(73) | 175(2) |
| C(26)-C(27)-C(30)-C(29) | -175(2) | C(75)-C(73)-C(74)-C(71) | 159(2) |
| O(8)-C(27)-C(30)-C(23) | 178.1(17) | N(4)-C(73)-C(74)-C(71) | -18(3) |
| C(26)-C(27)-C(30)-C(23) | 4(3) | C(75)-C(73)-C(74)-C(67) | -16(4) |
| C(24)-C(23)-C(30)-C(29) | 176(2) | N(4)-C(73)-C(74)-C(67) | 167.5(19) |
| C(24)-C(23)-C(30)-C(27) | -3(3) | N(4)-C(73)-C(75)-C(76) | -3(3) |
| N(2)-C(29)-C(31)-C(32) | -3(4) | C(74)-C(73)-C(75)-C(76) | -180(2) |
| C(30)-C(29)-C(31)-C(32) | -180(2) | C(73)-C(75)-C(76)-O(21) | -177(2) |
| C(29)-C(31)-C(32)-O(9) | -179(3) | C(73)-C(75)-C(76)-C(77) | 2(4) |
| C(29)-C(31)-C(32)-C(33) | 2(4) | O(21)-C(76)-C(77)-C(78) | 178(2) |
| O(9)-C(32)-C(33)-C(34) | 179(2) | C(75)-C(76)-C(77)-C(78) | -1(4) |
| C(31)-C(32)-C(33)-C(34) | -1(3) | O(21)-C(76)-C(77)-C(79) | -5(4) |
| O(9)-C(32)-C(33)-C(35) | -1(4) | C(75)-C(76)-C(77)-C(79) | 176(2) |
| C(31)-C(32)-C(33)-C(35) | 179(2) | C(73)-N(4)-C(78)-C(77) | -3(3) |
| C(29)-N(2)-C(34)-C(33) | -4(3) | C(72)-N(4)-C(78)-C(77) | -174(2) |
| C(28)-N(2)-C(34)-C(33) | -174.8(18) | C(79)-C(77)-C(78)-N(4) | -175(3) |
| C(35)-C(33)-C(34)-N(2) | -178(2) | C(76)-C(77)-C(78)-N(4) | 1(4) |
| C(32)-C(33)-C(34)-N(2) | 2(3) | C(80)-O(23)-C(79)-O(22) | -12(5) |
| C(36)-O(11)-C(35)-O(10) | -3(4) | C(80)-O(23)-C(79)-C(77) | 178(3) |
| C(36)-O(11)-C(35)-C(33) | 176(3) | C(78)-C(77)-C(79)-O(22) | -179(4) |
| C(34)-C(33)-C(35)-O(10) | 173(4) | C(76)-C(77)-C(79)-O(22) | 4(7) |
| C(32)-C(33)-C(35)-O(10) | -7(5) | C(78)-C(77)-C(79)-O(23) | -12(5) |
| C(34)-C(33)-C(35)-O(11) | -5(4) | C(76)-C(77)-C(79)-O(23) | 171(3) |
| C(32)-C(33)-C(35)-O(11) | 175(2) | O(20)-C(72)-C(81)-C(82) | -132.8(19) |
| O(8)-C(28)-C(37)-C(38) | -131.6(19) | N(4)-C(72)-C(81)-C(82) | 109(2) |
| N(2)-C(28)-C(37)-C(38) | 107(2) | O(20)-C(72)-C(81)-S(4) | 50(2) |
| O(8)-C(28)-C(37)-S(2) | 54(2) | N(4)-C(72)-C(81)-S(4) | -68(2) |
| N(2)-C(28)-C(37)-S(2) | -68(2) | C(84)-S(4)-C(81)-C(82) | 0.1(18) |
| C(40)-S(2)-C(37)-C(38) | 0.8(17) | C(84)-S(4)-C(81)-C(72) | 177.1(19) |
| C(40)-S(2)-C(37)-C(28) | 176(2) | C(72)-C(81)-C(82)-C(83) | -177.6(19) |
| C(28)-C(37)-C(38)-C(39) | -176(2) | S(4)-C(81)-C(82)-C(83) | 0(2) |
| S(2)-C(37)-C(38)-C(39) | -1(2) | C(81)-C(82)-C(83)-C(84) | 1(3) |
| C(37)-C(38)-C(39)-C(40) | 0(3) | C(82)-C(83)-C(84)-S(4) | -1(4) |
| C(38)-C(39)-C(40)-S(2) | 0(3) | C(81)-S(4)-C(84)-C(83) | 0(3) |
| C(37)-S(2)-C(40)-C(39) | -1(2) | C(69)-O(19)-C(85)-C(86) | 144(4) |
| C(25)-O(7)-C(41)-C(42) | 177(3) | O(19)-C(85)-C(86)-C(87) | 55(5) |
| C(52)-C(45)-C(46)-C(47) | 0(3) | C(85)-C(86)-C(87)-O(24) | -168(4) |
實驗例1:式(I)化合物的HBV體外活性測試
實驗材料:
1.細胞系:HepG2.2.15 細胞
HepG2.2.15 細胞培養基 (DMEM/F12,Invitrogen-11330032;10%血清,Invitrogen-10099141;100 units/ml青黴素和100 µg/ml鏈黴素,Hyclone-SV30010;1% 非必需胺基酸,Invitrogen-11140050;2毫米 L-GLUTAMINE,Invitrogen-25030081;300 μg/ml Geneticin,Invitrogen-10131027
2.試劑:
胰酶(Invitrogen-25300062)
DPBS (Corning-21031CVR)
二甲基亞碸(Sigma-D2650-100ML)
高通量DNA純化試劑盒(QIAamp 96 DNA Blood Kit,Qiagen-51162)
定量快速啟動通用探針試劑(FastStart Universal Probe Master,Roche-04914058001)
B型肝炎表面抗原定量檢測試劑盒(安圖生物,CL 0310)
3.耗材與儀器:
96孔細胞培養板(Corning-3599)
CO2
培養箱(HERA-CELL-240)
光學封板膜(ABI-4311971)
定量PCR 96孔板(Applied Biosystems-4306737)
螢光定量PCR儀(Applied Biosystems-7500 real time PCR system)
實驗方法:
1.種HepG2.2.15細胞(4x104
細胞/孔)到96孔板,在37℃,5 % CO2
培養過夜。
2.第二天,稀釋化合物,共8個濃度,3倍梯度稀釋。加不同濃度化合物到培養孔中,雙複孔。培養液中二甲基亞碸的終濃度為0.5%。10 µM ETV作為100% 抑制對照;0.5% 的二甲基亞碸作為0% 抑制對照。
3.第五天,更換含有化合物的新鮮培養液。
4.第八天收取培養孔中的培養液,取部分樣品ELISA測定B肝病毒S抗原的含量;取部分樣品使用高通量DNA純化試劑盒(Qiagen-51162)提取DNA。
5.PCR反應液的配製如表7所示:
表7 PCR 反應液的配製
前引物序列:GTGTCTGCGGCGTTTTATCA
後引物序列:GACAAACGGGCAACATACCTT
探針序列:5'+ FAM + CCTCTKCATCCTGCTGCTATGCCTCATC + TAMRA -3'
6.1在96孔PCR板中每孔加入15 µL的反應混合液,然後每孔加入10 µl的樣品DNA或HBV DNA的標準品。
6.2 PCR的反應條件為:95℃ 加熱10分鐘,然後95℃變性15秒,60℃延伸1分鐘,共40個循環。
6.3 ELISA測定B肝病毒S抗原的含量取50µl樣品和標準品分別加入到反應板中,再每孔分別加入50µL酶結合物,震盪混勻,37℃溫浴60分鐘,然後用洗液洗板5次,再每孔加入50µL發光基質,混勻,室溫避光反應10分鐘,最後用酶標儀檢測化學發光強度。
6.4 數據分析:
計算抑制百分比:% Inh. =(1-樣品中的值/二甲基亞碸對照值)×100。
計算EC50
:使用GraphPad Prism軟件計算化合物對HBV的50%抑制濃度(EC50
)值。
| 項目 | 配置1個孔所需體積 (微升) | 配置80個孔所需體積 (微升) |
| 定量快速啟動通用探針試劑 | 12.5 | 1000 |
| 前引物 (10微莫耳) | 1 | 80 |
| 後引物 (10微莫耳) | 1 | 80 |
| 探針 (10微莫耳) | 0.5 | 40 |
實驗結果如表8所示:
表8:體外活性測試結果
| 實施例 | HBV-DNA EC50 (nM) | HBsAg EC50 (nM) |
| 式(I)化合物 | 1.13 | 1.54 |
實驗結論:式(I)化合物能有效抑制HBV-DNA和B肝表面抗原(HBsAg)。
雖然本發明已以實施例揭露如上,然其並非用以限定本發明,本發明所屬技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作些許之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。
無
圖1為式(I)化合物A晶型的Cu-Kα輻射的XRPD譜圖。
圖2為式(I)化合物A晶型的DSC譜圖。
圖3為式(I)化合物A晶型的TGA譜圖。
圖4為式(II)化合物的單晶X射線衍射立體結構橢球圖。
Claims (16)
- 如請求項1所述的A晶型,其X射線粉末衍射圖譜在下列2θ角處具有特徵衍射峰:6.30±0.20°、9.30±0.20°、9.84±0.20°、12.84±0.20°、18.68±0.20°、20.16±0.20°、21.26±0.20°、23.06±0.20°、24.00±0.20°、25.38±0.20°。
- 如請求項2所述的A晶型,其X射線粉末衍射圖譜在下列2θ角處具有特徵衍射峰:6.302°、7.883°、9.301°、9.842°、12.838°、15.436°、16.580°、18.124°、18.680°、19.459°、20.161°、20.800°、21.262°、21.704°、23.057°、24.000°、24.837°、25.382°、26.244°、26.558°、27.740°、28.119°、28.827°、29.502°、29.880°、30.261°、30.762°、31.678°、32.595°、33.061°、34.347°、35.235°、35.738°、36.642°、38.619°和39.558°。
- 如請求項1所述的A晶型,其XRPD圖譜如圖1所示。
- 如請求項1~5任意一項所述的A晶型,其差示掃描量熱曲線在224.58℃±3℃處具有吸熱峰的峰值。
- 如請求項6所述的A晶型,其DSC圖譜如圖2所示。
- 如請求項1~5任意一項所述的A晶型,其熱重分析曲線在200.00±3℃時失重達0.127%;在250±3℃時又失重達0.224%。
- 如請求項8所述的A晶型,其TGA圖譜如圖3所示。
- 如請求項10所述的製備方法,其中醇類溶劑、丙酮、乙腈與水的體積比例選自1:1~3。
- 如請求項10或11所述的製備方法,其中醇類溶劑選自甲醇、乙醇或異丙醇。
- 如請求項10所述的製備方法,其中攪拌溫度選自25℃~65℃。
- 如請求項10所述的製備方法,其中攪拌時間選自1小時~72小時。
- 如請求項10所述的製備方法,其中式(I)化合物與溶劑的重量比選自1:1~30。
- 一種如請求項1~9任意一項所述的A晶型在製備治療慢性B型肝炎相關藥物上的應用。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910887908 | 2019-09-19 | ||
| CN201910887908.1 | 2019-09-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202115046A TW202115046A (zh) | 2021-04-16 |
| TWI746177B true TWI746177B (zh) | 2021-11-11 |
Family
ID=74883899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109132274A TWI746177B (zh) | 2019-09-19 | 2020-09-18 | 一種b肝表面抗原抑制劑的晶型及其應用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11807647B2 (zh) |
| EP (1) | EP4032895A4 (zh) |
| JP (1) | JP2022548746A (zh) |
| KR (1) | KR102623169B1 (zh) |
| CN (1) | CN112521400B (zh) |
| AU (1) | AU2020347724B2 (zh) |
| CA (1) | CA3151696A1 (zh) |
| TW (1) | TWI746177B (zh) |
| WO (1) | WO2021052447A1 (zh) |
| ZA (1) | ZA202204273B (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018161960A1 (zh) * | 2017-03-09 | 2018-09-13 | 福建广生堂药业股份有限公司 | 乙型肝炎病毒表面抗原抑制剂 |
| TWI726497B (zh) * | 2018-11-22 | 2021-05-01 | 大陸商福建廣生堂藥業股份有限公司 | 一種b肝表面抗原抑制劑的晶型 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130251647A1 (en) * | 2011-09-20 | 2013-09-26 | Basf Se | Low molecular weight modulators of the cold menthol receptor trpm8 and use thereof |
| HK1244281B (zh) * | 2015-02-11 | 2020-02-07 | F. Hoffmann-La Roche Ag | 治疗和预防乙型肝炎病毒感染的2-氧代-6,7-二氢苯并[a]喹嗪-3-甲酸衍生物 |
| CN107759585A (zh) * | 2016-07-29 | 2018-03-06 | 银杏树药业(苏州)有限公司 | 一种异喹啉类化合物及其药用组合物和作为抗病毒药物的应用 |
| CN108884107B (zh) * | 2017-05-22 | 2019-08-09 | 福建广生堂药业股份有限公司 | 乙型肝炎病毒表面抗原抑制剂 |
| WO2019169539A1 (en) | 2018-03-05 | 2019-09-12 | Pharmaresources (Shanghai) Co., Ltd. | Novel oxa-and aza-tricyclic 4-pyridone-3-carboxylic acid for treatment and prophylaxis of hepatitis b virus infection |
-
2020
- 2020-09-18 KR KR1020227012832A patent/KR102623169B1/ko active Active
- 2020-09-18 CA CA3151696A patent/CA3151696A1/en active Pending
- 2020-09-18 AU AU2020347724A patent/AU2020347724B2/en active Active
- 2020-09-18 EP EP20865773.4A patent/EP4032895A4/en not_active Withdrawn
- 2020-09-18 CN CN202010991558.6A patent/CN112521400B/zh active Active
- 2020-09-18 WO PCT/CN2020/116051 patent/WO2021052447A1/zh not_active Ceased
- 2020-09-18 JP JP2022517874A patent/JP2022548746A/ja active Pending
- 2020-09-18 TW TW109132274A patent/TWI746177B/zh active
- 2020-09-18 US US17/760,818 patent/US11807647B2/en active Active
-
2022
- 2022-04-14 ZA ZA2022/04273A patent/ZA202204273B/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018161960A1 (zh) * | 2017-03-09 | 2018-09-13 | 福建广生堂药业股份有限公司 | 乙型肝炎病毒表面抗原抑制剂 |
| TWI726497B (zh) * | 2018-11-22 | 2021-05-01 | 大陸商福建廣生堂藥業股份有限公司 | 一種b肝表面抗原抑制劑的晶型 |
Also Published As
| Publication number | Publication date |
|---|---|
| US11807647B2 (en) | 2023-11-07 |
| EP4032895A4 (en) | 2023-12-20 |
| CN112521400B (zh) | 2022-05-03 |
| EP4032895A1 (en) | 2022-07-27 |
| AU2020347724A1 (en) | 2022-04-28 |
| TW202115046A (zh) | 2021-04-16 |
| ZA202204273B (en) | 2022-12-21 |
| WO2021052447A1 (zh) | 2021-03-25 |
| US20220402939A1 (en) | 2022-12-22 |
| AU2020347724B2 (en) | 2024-09-19 |
| CA3151696A1 (en) | 2021-03-25 |
| JP2022548746A (ja) | 2022-11-21 |
| KR20220066118A (ko) | 2022-05-23 |
| CN112521400A (zh) | 2021-03-19 |
| KR102623169B1 (ko) | 2024-01-11 |
| BR112022005101A2 (pt) | 2022-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6783424B2 (ja) | B型肝炎ウイルス表面抗原阻害剤 | |
| CN103601683B (zh) | 苯并杂环类化合物及其制备方法和用途 | |
| CN110372723B (zh) | 乙型肝炎病毒表面抗原抑制剂 | |
| KR20150133792A (ko) | 형광-hap: 세포 중의 hbv 코어를 위한 진단 염색제 | |
| TWI746177B (zh) | 一種b肝表面抗原抑制劑的晶型及其應用 | |
| TWI726497B (zh) | 一種b肝表面抗原抑制劑的晶型 | |
| RU2823673C1 (ru) | Способ получения кристаллической формы ингибитора поверхностного антигена вируса гепатита в | |
| HK40068663A (zh) | 一种乙肝表面抗原抑制剂的晶型及其应用 | |
| BR112022005101B1 (pt) | Forma cristalina de inibidor de antígeno de superfície de hepatite b e aplicação da mesma | |
| KR20150119342A (ko) | 줄기세포를 간세포로 개선되게 분화시키기 위한 화합물 | |
| CN115197164B (zh) | 新型噻唑类化合物及其制备方法和用途 | |
| CN115181096A (zh) | 一种通过酯键键合的3tc-pa新化合物及其应用 | |
| CN107056775A (zh) | 丙型肝炎病毒ns5b聚合酶抑制剂 | |
| CN106632004B (zh) | 吡啶酮类衍生物及其制备方法与应用 | |
| HK40052444B (zh) | 一种乙肝表面抗原抑制剂的晶型 | |
| HK40052444A (zh) | 一种乙肝表面抗原抑制剂的晶型 | |
| CN109232555A (zh) | 一种抗hbv的含氧杂环化合物 |